Sponsor Pipeline

PYC Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
2
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06970106 Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal… OPA1 Gene Mutation Recruiting
NCT06852963 A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001… Retinitis Pigmentosa 11 Active, Not Recruiting
Phase 1
NCT06714006 Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered… Autosomal Dominant Polycystic Kidney Disease (ADPKD) Recruiting
NCT06461286 SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew) OPA1 Gene Mutation Active, Not Recruiting
Not specified
NCT05573984 Natural History of PRPF31 Mutation-Associated Retinal Dystrophy Retinitis Pigmentosa Active, Not Recruiting
Disease Areas
Get alerts when PYC Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free